Axtria Announces its First Ignite Leadership Award Honorees [Yahoo! Finance]
Regeneron Pharmaceuticals, Inc. (REGN)
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.regeneron.com
Company Research
Source: Yahoo! Finance
June 18, 2024 /PRNewswire/ -- Axtria, a global leader in cloud software and data analytics for the life sciences industry, has announced the recipients of its first-ever Ignite Leadership Awards, honoring leaders who have demonstrated excellence in driving innovation, transformation, and value creation in their organizations and the industry. This first cohort of annual honorees was presented at the Axtria Ignite 2024 conference, the premier life sciences commercial leaders' event held on June 12 and 13 in Princeton, N.J. "We are thrilled to honor these outstanding leaders with an Ignite Leadership Award, which celebrates their achievements and contributions to the life sciences industry," said Jassi Chadha , CEO and co-founder of Axtria. "Each individual exemplifies the qualities of vision, innovation, transformation, authority, and championing that we value and admire at Axtria." 2024 Ignite Leadership Award Honorees: Arvind Balasundaram , Executive Director, Commercial Insigh
Show less
Read more
Impact Snapshot
Event Time:
REGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
REGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
REGN alerts
High impacting Regeneron Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
REGN
News
- Regeneron-Sanofi Drug Wins FDA Approval To Treat COPD [Yahoo! Finance]Yahoo! Finance
- Dupixent® (dupilumab) Approved in the U.S. as the First-ever Biologic Medicine for Patients with COPD [Yahoo! Finance]Yahoo! Finance
- Dupixent® (dupilumab) Approved in the U.S. as the First-ever Biologic Medicine for Patients with COPDGlobeNewswire
- Dupixent® (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients with Chronic Obstructive Pulmonary Disease (COPD)GlobeNewswire
- Regeneron to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on October 31, 2024GlobeNewswire
REGN
Earnings
- 8/1/24 - Beat
REGN
Sec Filings
- 9/5/24 - Form 4
- 9/5/24 - Form 4
- 9/5/24 - Form 4
- REGN's page on the SEC website